Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice

• Hauptverfasser: M. M. Loukianov (Verfasst von), A. V. Kontsevaya (Verfasst von), A. O. Myrzamatova (Verfasst von), M. B. Khudyakov (Verfasst von), E. Y. Okshina (Verfasst von), E. V. Kudryashov (Verfasst von)
• Format: Buch
• Veröffentlicht: Столичная издательская компания, 2020-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Aim. To evaluate the structure of multimorbidity, outcomes and the potential effect of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian clinical practice.Material and methods. The data of 10 registries with the inclusion of 22957 people, inc...